Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Non Operating Income (2021 - 2022)

Historic Non Operating Income for ProQR Therapeutics (PRQR) over the last 2 years, with Q3 2022 value amounting to $625130.1.

  • ProQR Therapeutics' Non Operating Income rose 29928.25% to $625130.1 in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2021, which is 2221.01% down from last year.
  • According to the latest figures from Q3 2022, ProQR Therapeutics' Non Operating Income is $625130.1, which was up 29928.25% from $128046.8 recorded in Q2 2022.
  • ProQR Therapeutics' Non Operating Income's 5-year high stood at $3.0 million during Q2 2021, with a 5-year trough of -$313690.5 in Q3 2021.